Defining disease stability in COPD: Evidence from Phase 3 clinical trials

Journal:

American Journal of Respiratory and Critical Care Medicine

Published:

2026-06-11

DOI:

10.1093/ajrccm/aamag292

Affiliations:

9

Authors:

9

Go to article

Institutions	Authors	Share
GSK, United Kingdom (UK)	5.000000	0.56
University of Exeter, United Kingdom (UK)	1.000000	0.11
The University of Alabama at Birmingham (UAB), United States of America (USA)	1.000000	0.11
University of Michigan (U-M), United States of America (USA)	1.000000	0.11
The University of Manchester (UoM), United Kingdom (UK)	0.333333	0.04
Manchester University NHS Foundation Trust (MFT), United Kingdom (UK)	0.333333	0.04
IQVIA United Kingdom, United Kingdom (UK)	0.333333	0.04